Piceatannol Alleviates IClostridium perfringens/I Virulence by Inhibiting Perfringolysin O

• Published in: Molecules (Basel, Switzerland) Vol. 27; no. 16
• Main Authors: Wang, Guizhen, Liu, Hongtao, Gao, Yawen, Niu, Xiaodi, Deng, Xuming, Wang, Jianfeng, Feng, Haihua, Guo, Zhimin, Qiu, Jiazhang
• Format: Journal Article
• Language: English
• Published: MDPI AG 01.08.2022
• Subjects: Bacterial infections; Clostridium; Diagnosis; Health aspects; Risk factors; China
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules27165145

Clostridium perfringens (C. perfringens) is an important foodborne pathogen that can cause diseases such as gas gangrene and necrotizing enteritis in a variety of economic animals, seriously affecting public health and the economic benefits and healthy development of the livestock and poultry breeding industry. Perfringolysin O (PFO) is an important virulence factor of C. perfringens and plays critical roles in necrotic enteritis and gas gangrene, rendering it an ideal target for developing new drugs against infections caused by this pathogen. In this study, based on biological activity inhibition assays, oligomerization tests and computational biology assays, we found that the foodborne natural component piceatannol reduced pore-forming activity with an inhibitory ratio of 83.84% in the concentration of 16 µg/mL (IC[sub.50] = 7.83 µg/mL) by binding with PFO directly and changing some of its secondary structures, including 3-Helix, A-helix, bend, and in turn, ultimately affecting oligomer formation. Furthermore, we confirmed that piceatannol protected human intestinal epithelial cells from the damage induced by PFO with LDH release reduced by 38.44% at 16 µg/mL, based on a cytotoxicity test. By performing an animal experiment, we found the C. perfringens clones showed an approximate 10-fold reduction in infected mice. These results suggest that piceatannol may be a candidate for anti-C. perfringens drug development.